Browsing: neuroscience

The FDA launched the Neuroscience Advancement and Innovation Nexus to accelerate medical product development for brain conditions, starting with Alzheimer’s prevention.

A small pilot study from UCSF finds that psilocybin significantly lowers inflammatory markers in Parkinson’s patients, hinting at broader anti-inflammatory benefits.

Researchers at the University of Bonn have reversed more than 60 years of aging in human cells by transforming old blood cells into young neural stem cells.

Researchers block a protein to stop T cells from entering the brain, reducing Alzheimer’s brain damage in mice without removing toxic tau protein tangles.

Karl Deisseroth, Peter Hegemann, and Georg Nagel have won the 2026 Nobel Prize for developing optogenetics, a method to control brain cells with light.

Researchers found that oligodendrocytes, cells that protect nerve fibers, can become dysfunctional with age and contribute to cognitive decline.

Researchers at UC Berkeley have mapped the brain circuit controlling growth hormone release during deep sleep, revealing a feedback loop that affects metabolism and wakefulness.

A rare examination of an Alzheimer’s patient’s brain reveals that regions where amyloid plaques were cleared showed significantly less tau damage than areas where plaques remained.

UCLA researchers found that specific gut bacteria and metabolic byproducts correlate with faster brain aging in healthy adults, potentially offering early warning signs for cognitive decline.